Now showing items 1-1 of 1

    • Background Morbidity In HIV Vaccine Trial Participants From Various Geographic Regions As Assessed By Unsolicited Adverse Events 

      Schmidt, C; Smith, C; Barin, B; Bakhtyari, A; Bart, PA; Bekker, LG; Chomba, E; Clumeck, N; Hoosen, A; Jaoko Walter G.; Kaleebu, P; Karita, E; Keefer, MC; van Lunzen, J; McMichael, A; Mehendale, S; Peters, B; Ramanathan, VD; Robinson, A; Rockstroh, J; Vardas, E; Vets, E; Weber, J; Graham, BS; Than, S; Excler, JL; Kochhar, S; Heald, A; Fast, PE (University of NairobiDepartment of Infectious Diseases, 2012-05)
      BACKGROUND: Recently, more clinical trials are being conducted in Africa and Asia, therefore, background morbidity in the respective populations is of interest. Between 2000 and 2007, the International AIDS Vaccine ...